Your browser doesn't support javascript.
loading
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells.
Krombach, Julia; Hennel, Roman; Brix, Nikko; Orth, Michael; Schoetz, Ulrike; Ernst, Anne; Schuster, Jessica; Zuchtriegel, Gabriele; Reichel, Christoph A; Bierschenk, Susanne; Sperandio, Markus; Vogl, Thomas; Unkel, Steffen; Belka, Claus; Lauber, Kirsten.
Afiliación
  • Krombach J; Department of Radiation Oncology, University Hospital, Munich, Germany.
  • Hennel R; Department of Radiation Oncology, University Hospital, Munich, Germany.
  • Brix N; Department of Radiation Oncology, University Hospital, Munich, Germany.
  • Orth M; Department of Radiation Oncology, University Hospital, Munich, Germany.
  • Schoetz U; German Cancer Consortium (DKTK), Munich, Germany.
  • Ernst A; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schuster J; Department of Radiation Oncology, University Hospital, Munich, Germany.
  • Zuchtriegel G; Department of Radiotherapy and Radiooncology, Philipps-University Marburg, University Hospital Gießen and Marburg, Marburg, Germany.
  • Reichel CA; Department of Radiation Oncology, University Hospital, Munich, Germany.
  • Bierschenk S; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.
  • Sperandio M; Department of Radiation Oncology, University Hospital, Munich, Germany.
  • Vogl T; Department of Otorhinolaryngology, University Hospital, Munich, Germany.
  • Unkel S; Walter Brendel Centre of Experimental Medicine, University Hospital, Munich, Germany.
  • Belka C; Translational research in haematology/oncology, Institute of Experimental Infectious Diseases and Cancer Research, Division of the University Children's Hospital of Zurich, Zurich, Switzerland.
  • Lauber K; Department of Otorhinolaryngology, University Hospital, Munich, Germany.
Oncoimmunology ; 8(1): e1523097, 2019.
Article en En | MEDLINE | ID: mdl-30546963

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article País de afiliación: Alemania